The treatment of diabetic animals with the A2AR antagonist reduced the number of animals with retinal vascular fluorescein leakage (Fig. 8A,B), suggesting that the A2AR antagonist restored the BRB integrity lost in the course of diabetes. The gene discussed is ADORA2A; the disease is diabetes mellitus.